ProCE Banner Activity

Clinical Trial Spotlight and Future Directions

Slideset Download

Download these slides from a live symposium for information on key clinical trials in AML as well as future directions.

Released: December 09, 2022

Expiration: December 08, 2023

No longer available for credit.

Share

Faculty

Daniel Pollyea

Daniel Pollyea, MD, MS

Professor of Medicine
Clinical Director of Leukemia Services
Associate Chief of Clinical Affairs
Robert H. Allen MD Chair in Hematology Research
Division of Hematology
University of Colorado School of Medicine
Aurora, Colorado

Provided by

Provided by National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC

ProCE Banner

Supporters

Astellas Text

Daiichi Sankyo, Inc.

Gilead Sciences, Inc.

Servier Pharmaceuticals

Syndax

Partners

Clinical Care Options, LLC

ProCE Banner

Faculty Disclosure

Primary Author

Daniel Pollyea, MD, MS

Professor of Medicine
Clinical Director of Leukemia Services
Associate Chief of Clinical Affairs
Robert H. Allen MD Chair in Hematology Research
Division of Hematology
University of Colorado School of Medicine
Aurora, Colorado

Daniel Pollyea, MD, MS: consultant/advisor/speaker: AbbVie, Arcellx, AstraZeneca, BeiGene, BerGen Bio, Bristol-Myers Squibb, Genentech, Hibercell, Immunogen, Jazz, Kura, LINK, Magenta, Medivir, Novartis, Qihan, Ryvu, Syros, Zentalis; researcher: AbbVie, Bristol-Myers Squibb, Karyopharm, Teva; data and safety monitoring boards: Aptevo, Glycomimetics.